Maria Boustani, MD
Pulmonary Disease · Beckley, WVNPI 1518917632
Payments from drug & device makers
Across 395 payments — averaging $1678.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$565K
- GSK$63K
- Boehringer Ingelheim$15K
- Sunovion Pharmaceuticals Inc.$6K
- Sanofi$5K
- Regeneron Healthcare Solutions, Inc.$3K
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 64 | $565,118 |
| GSK | 74 | $62,992 |
| Boehringer Ingelheim | 27 | $15,348 |
| Sunovion Pharmaceuticals Inc. | 18 | $6,389 |
| Sanofi | 21 | $4,654 |
| Regeneron Healthcare Solutions, Inc. | 17 | $2,700 |
| Boehringer Ingelheim International GmbH | 11 | $2,481 |
| UCB, Inc. | 61 | $718 |
| Novartis | 17 | $315 |
| Merck | 5 | $250 |
| Johnson & Johnson | 14 | $238 |
| Amgen | 9 | $185 |
| Mallinckrodt Hospital Products Inc. | 4 | $174 |
| ANI Pharmaceuticals, Inc. | 6 | $164 |
| Regeneron | 3 | $161 |
| AstraZeneca(2 entities) | 5 | $154 |
| United Therapeutics Corporation | 1 | $119 |
| Baxter Healthcare | 7 | $118 |
| Radius Health, Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $94 |
| Bristol Myers Squibb | 2 | $88 |
| Sandoz | 4 | $60 |
| Shire North American Group Inc | 1 | $51 |
| Genentech USA, Inc. | 1 | $40 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Verona Pharma, Inc. | 1 | $32 |
| Organon | 2 | $31 |
| Mylan Specialty L.p. | 2 | $27 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Apria Healthcare LLC | 1 | $18 |
| Insmed, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
| Advanced Respiratory, Inc | 1 | $12 |
| Bioventus LLC | 1 | $11 |
How this compares
$662,985 in reported general payments places this provider in the 95th percentile of 89 pulmonary disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Beckley
- Ramzi HaddadinBeckley$43K
- Charles PorterfieldBeckley$8K
- Shirkant BembalkarBeckley$746
- William PowersBeckley$589
- Loay Al AsadiCharleston$461K
- Melvin SaludesGlen Dale$255K
- Amro Al-AstalHuntington$231K
- Roger AbrahamsMorgantown$177K
- Houssein YounessMartinsburg$31K
- Salam RajjoubBridgeport$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.